News and Announcements
Mafematica named one of 10 best fintechs in Australia and NZ by UK Department for International Trade
- Published September 25, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Mafematica has been announced as one of the 10 best fintechs in Australia and NZ by the Department for International Trade. The company will be awarded a trip to the UK from 23 Sept to 27 Sept.
On this fintech mission, Mafematica will be immersed in the UK’s fintech scene, meet potential customers, be challenged, create valuable networks and be blown away by the depth of talent in the UK.
About Mafematica
Mafematica is a SaaS fintech focused on the SMSF sector (600,000+ funds) and offers share packages and investment portfolios. Its unique stochastic algorithm forecasts investment outcomes for retirement and savings plans. Its direct interfaces with existing accounting, banking & execution packages provide time savings and efficiencies for users. Mafematica has strong international potential.
Company Updates
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Backed By Leading Investment Groups and Family Offices
